Picard Medical, Inc. Common Stock (PMI)

SAN DIEGO, Feb. 06, 2026 (GLOBE NEWSWIRE) --

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Picard Medical, Inc. (“Picard” or the “Company”) (NYSE: PMI) securities between September 2, 2025 and October 31, 2025, inclusive (the “Class Period”). Picard investors have until April 3, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Picard Medical, Inc. (“Picard” or the “Company”) (NYSE: PMI) investors concerning the Company’s possible violations of the federal securities laws.

Law Offices of Howard G. Smith announces an investigation on behalf of Picard Medical, Inc. (“Picard” or the “Company”) (NYSE: PMI) investors concerning the Company’s possible violations of federal securities laws.

The DJS Law Group reminds investors of a class action lawsuit against Picard Medical, Inc. (“Picard” or “the Company”) (NYSE American: PMI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Law Offices of Frank R. Cruz announces an investigation of Picard Medical, Inc. (“Picard” or the “Company”) (NYSE: PMI) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Picard Medical, Inc. (“Picard” or “the Company”) (NYSE American: PMI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Picard Medical To Contact Him Directly To Discuss Their Options

Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, today announced that it has filed a class action lawsuit against Defendants Picard Medical Inc., Patrick NJ Schnegelsberg, Matt Schuster, Yuncai “Richard” Fang, Chris Hsieh, Westpark Capital, Inc., Sentinel Brokers Company, Inc., R.F. Lafferty & Co. Inc., American Trust Investments, and MaloneBailey, LLP (collectively, the “Defendants”). The action, which was filed in the U.S. District Court for the Northern District of California and captioned Louie v. Picard Medical, Inc. et al., Case No. 5:26-cv-01024, asserts claims under §§10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who purchased Picard Medical Securities (“PMI”) between September 2, 2025, and October 31, 2025, inclusive (the “Class Period”), and who were damaged thereby. The lead plaintiff deadline in this action is April 3, 2026.

Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Picard Medical, Inc. (NYSE American: PMI) between September 2, 2025 and October 31, 2025, inclusive (the “Class Period”). Picard claims to design, manufacture, and sell medical device products.

Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Picard Medical, Inc. (NYSE: PMI) securities between September 2, 2025 and October 31, 2025. Picard Medical claims to engage in designing, manufacturing, production, supply, marketing, and sale of medical device products.